267 related articles for article (PubMed ID: 36899268)
1. SPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations.
Voss SD
Pediatr Radiol; 2023 Jun; 53(7):1443-1453. PubMed ID: 36899268
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
4. PET-MR and SPECT-MR multimodality probes: Development and challenges.
Yang CT; Ghosh KK; Padmanabhan P; Langer O; Liu J; Eng DNC; Halldin C; Gulyás B
Theranostics; 2018; 8(22):6210-6232. PubMed ID: 30613293
[TBL] [Abstract][Full Text] [Related]
5. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
6. PET/MRI vs PET/CT in Head and Neck Imaging: When, Why, and How?
Ryan JL; Aaron VD; Sims JB
Semin Ultrasound CT MR; 2019 Oct; 40(5):376-390. PubMed ID: 31635765
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP.
Queiroz MA; Barbosa FG; Buchpiguel CA; Cerri GG
Rev Assoc Med Bras (1992); 2018 Jan; 64(1):71-84. PubMed ID: 29561945
[TBL] [Abstract][Full Text] [Related]
8. Dose Optimization of Hybrid Imaging.
Fahey FH
Health Phys; 2019 Feb; 116(2):179-183. PubMed ID: 30585961
[TBL] [Abstract][Full Text] [Related]
9. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
[TBL] [Abstract][Full Text] [Related]
10. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
11. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
12. Hybrid imaging of neuroendocrine tumors in the heart: Union is strength.
Marketou ME; Kapsoritakis N; Bourogianni O; Patrianakos A; Kochiadakis G; Plevritaki A; Papadaki S; Zervakis S; Parthenakis F; Koukouraki S
J Nucl Cardiol; 2023 Feb; 30(1):298-312. PubMed ID: 34622428
[TBL] [Abstract][Full Text] [Related]
13. Comparison of FDG PET/MRI and FDG PET/CT in Pediatric Oncology in Terms of Anatomic Correlation of FDG-positive Lesions.
Uslu-Beşli L; Atay Kapucu LÖ; Karadeniz C; Akdemir ÜÖ; Pinarli FG; Aydos U; Okur A; Kaya Z; Samanci C; Karabacak NI
J Pediatr Hematol Oncol; 2019 Oct; 41(7):542-550. PubMed ID: 30933019
[TBL] [Abstract][Full Text] [Related]
14. Deep-learning-based methods of attenuation correction for SPECT and PET.
Chen X; Liu C
J Nucl Cardiol; 2023 Oct; 30(5):1859-1878. PubMed ID: 35680755
[TBL] [Abstract][Full Text] [Related]
15. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
16. [Why is PET/CT essential in urooncology?].
Borbély K; Géczi L; Kásler M
Magy Onkol; 2013 Dec; 57(4):282-96. PubMed ID: 24353995
[TBL] [Abstract][Full Text] [Related]
17. Potential clinical applications of bimodal PET-MRI or SPECT-MRI agents.
de Rosales RT
J Labelled Comp Radiopharm; 2014 Apr; 57(4):298-303. PubMed ID: 24395384
[TBL] [Abstract][Full Text] [Related]
18. Dose reduction in pediatric hybrid and planar imaging.
Gelfand MJ
Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):379-88. PubMed ID: 20823806
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of MRI, SPECT, and PET in detecting renal cell carcinoma: a systematic review and meta-analysis.
Yin Q; Xu H; Zhong Y; Ni J; Hu S
BMC Cancer; 2022 Feb; 22(1):163. PubMed ID: 35148700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
